Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 64

Similar articles for PubMed (Select 23431348)

1.

Xiaoqinglong granules as add-on therapy for asthma: latent class analysis of symptom predictors of response.

Zha Q, Lin S, Zhang C, Chang C, Xue H, Lu C, Jiang M, Liu Y, Xiao Z, Liu W, Shang Y, Chen J, Wen M, Lu A.

Evid Based Complement Alternat Med. 2013;2013:759476. doi: 10.1155/2013/759476. Epub 2013 Feb 3.

2.

Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma : a placebo-controlled comparison.

Boonsawat W, Goryachkina L, Jacques L, Frith L.

Clin Drug Investig. 2008;28(2):101-11.

PMID:
18211118
3.

Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.

Vogelmeier C, Naya I, Ekelund J.

Clin Drug Investig. 2012 Jul 1;32(7):439-49. doi: 10.2165/11598840-000000000-00000.

PMID:
22607479
5.

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.

Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, Michele TM, Reiss TF, Nguyen HH, Bratton DL.

Pediatrics. 2001 Sep;108(3):E48.

PMID:
11533366
6.

[A clinical study on the significance of airway hyperresponsiveness monitoring in the adjustment of combined therapy for asthmatic patients].

Liu CT, Wang YM, Wang G, Tan CW, Pang YM.

Zhonghua Jie He He Hu Xi Za Zhi. 2007 Jul;30(7):498-503. Chinese.

PMID:
17961403
7.

Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).

Baumgarten C, Geldszus R, Behre U, Peslis N, Trautmann M; Viani-Initial Study Group.

Eur J Med Res. 2002 Jan 29;7(1):1-7.

PMID:
11827834
8.

Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.

Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.

Ann Allergy Asthma Immunol. 1999 Mar;82(3):257-65.

PMID:
10094216
9.

Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial.

Kavuru M, Melamed J, Gross G, Laforce C, House K, Prillaman B, Baitinger L, Woodring A, Shah T.

J Allergy Clin Immunol. 2000 Jun;105(6 Pt 1):1108-16.

PMID:
10856143
10.

[Influence of education level on self-evaluation and control of patients with bronchial asthma].

Zhao HJ, Cai SX, Tong WC, Li WJ, Fu L.

Nan Fang Yi Ke Da Xue Xue Bao. 2008 May;28(5):715-7. Chinese.

12.

Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma.

Johansson G, Andreasson EB, Larsson PE, Vogelmeier CF.

Pharmacoeconomics. 2006;24(7):695-708. Erratum in: Pharmacoeconomics. 2008;26(10):894.

PMID:
16802845
13.
14.

[Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].

Wang HY, Lin XP, Hao CL, Zhang CQ, Sun BQ, Zheng JP, Chen P, Sheng JY, Wu A, Zhong NS.

Zhonghua Jie He He Hu Xi Za Zhi. 2006 Oct;29(10):679-87. Chinese.

PMID:
17129496
15.

Efficacy, safety, and impact on quality of life of salmeterol in patients with moderate persistent asthma.

Busse WW, Casale TB, Murray JJ, Petrocella V, Cox F, Rickard K.

Am J Manag Care. 1998 Nov;4(11):1579-87.

16.

Evaluation of 3-5 months' add-on therapy with montelukast in patients with non-controlled asthma in Austria: the STAR open-label, real-world, observational study.

Schlick W, Pohl W, Pfeiffer KP, Aigner K, Forche G, Kneussl M, Zwick H.

Curr Med Res Opin. 2010 Mar;26(3):561-70. doi: 10.1185/03007990903523021.

PMID:
20050815
17.

Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.

Sorkness CA, Lemanske RF Jr, Mauger DT, Boehmer SJ, Chinchilli VM, Martinez FD, Strunk RC, Szefler SJ, Zeiger RS, Bacharier LB, Bloomberg GR, Covar RA, Guilbert TW, Heldt G, Larsen G, Mellon MH, Morgan WJ, Moss MH, Spahn JD, Taussig LM; Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute.

J Allergy Clin Immunol. 2007 Jan;119(1):64-72. Epub 2006 Nov 30. Erratum in: J Allergy Clin Immunol. 2007 Aug;120(2):285.

PMID:
17140647
19.

The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group.

Condemi JJ, Goldstein S, Kalberg C, Yancey S, Emmett A, Rickard K.

Ann Allergy Asthma Immunol. 1999 Apr;82(4):383-9.

PMID:
10227337
20.

Cost-effectiveness of salmeterol xinafoate/fluticasone propionate combination inhaler in chronic asthma.

Doull I, Price D, Thomas M, Hawkins N, Stamuli E, Tabberer M, Gosden T, Rudge H.

Curr Med Res Opin. 2007 May;23(5):1147-59.

PMID:
17519082
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk